Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2019 Jan;94(1):149-161.
doi: 10.1002/ajh.25325. Epub 2018 Nov 28.

Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency

Affiliations
Practice Guideline

Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency

Paola Bianchi et al. Am J Hematol. 2019 Jan.

Abstract

Pyruvate kinase deficiency (PKD) is the most common enzyme defect of glycolysis and an important cause of hereditary, nonspherocytic hemolytic anemia. The disease has a worldwide geographical distribution but there are no verified data regarding its frequency. Difficulties in the diagnostic workflow and interpretation of PK enzyme assay likely play a role. By the creation of a global PKD International Working Group in 2016, involving 24 experts from 20 Centers of Expertise we studied the current gaps in the diagnosis of PKD in order to establish diagnostic guidelines. By means of a detailed survey and subsequent discussions, multiple aspects of the diagnosis of PKD were evaluated and discussed by members of Expert Centers from Europe, USA, and Asia directly involved in diagnosis. Broad consensus was reached among the Centers on many clinical and technical aspects of the diagnosis of PKD. The results of this study are here presented as recommendations for the diagnosis of PKD and used to prepare a diagnostic algorithm. This information might be helpful for other Centers to deliver timely and appropriate diagnosis and to increase awareness in PKD.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

PB, BG, DJK, MMP, WB, EvB, PPG, RvW are scientific advisors to Agios Pharmaceuticals. The remaining authors declare no competing financial interests.

Figures

FIGURE 1
FIGURE 1
Effect of buffy-coat removal and RBC filtration on: (A) WBC, (B) platelets, and (C) reticulocytes (expressed as % of cells in whole blood). Effect of buffy-coat removal and RBC filtration on: (D) PK activity and (E) HK activity (expressed as % of normal values). (F) ROC curve analysis of PK activity assay
FIGURE 2
FIGURE 2
Diagnostic algorithm for diagnostic work-up for diagnosis of PK deficiency based on recommendations and consensus group work. Blue boxes represent the methods used in the diagnostic process

References

    1. Valentine WN, Tanaka KR, Miwa S. A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia. Trans Assoc Am Physicians. 1961; 74:100–110. - PubMed
    1. Canu G, De Bonis M, Minucci A, Capoluongo E. Red blood cell PK deficiency: an update of PK-LR gene mutation database. Blood Cells Mol Dis. 2016;57:100–109. - PubMed
    1. van Wijk PKLR Leiden Open Variation Database. https://grenada.lumc.nl/LOVD2/mendelian_genes/home.php?select_db=PKLR
    1. Zanella A, Fermo E, Bianchi P, Valentini G. Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br J Haematol. 2005; 130(1):11–25. - PubMed
    1. Beutler E Red cell enzyme defects as nondiseases and as diseases. Blood. 1979;54(1):1–7. - PubMed

Publication types

MeSH terms

Supplementary concepts